The untold story of PFAS alternatives: Insights into the occurrence, ecotoxicological impacts, and removal strategies in the aquatic environment.

Due to increasing regulations on the production and consumption of legacy per- and polyfluoroalkyl substances (PFAS), the global use of PFAS substitutes increased tremendously, posing serious environmental risks owing to their bioaccumulation, toxicity, and lack of removal strategies. This review summarized the spatial distribution of alternative PFAS and their ecological risks in global freshwater and marine ecosystems. Further, toxicological effects of novel PFAS in various freshwater and marine species were highlighted. Moreover, degradation mechanisms for alternative PFAS removal from aquatic environments were compared and discussed. The spatial distribution showed that 6:2 chlorinated polyfluorinated ether sulfonate (6:2 CI-PFAES, also known as F-53B) was the most dominant emerging PFAS found in freshwater. Additionally, the highest levels of PFBS and PFBA were observed in marine waters (West Pacific Ocean). Moreover, short-chain PFAS exhibited higher concentrations than long-chain congeners. The ecological risk quotients (RQs) for phytoplankton were relatively higher >1 than invertebrates, indicating a higher risk for freshwater phytoplankton species. Similarly, in marine water, the majority of PFAS substitutes exhibited negligible risk for invertebrates and fish, and posed elevated risks for phytoplanktons. Reviewed studies showed that alternative PFAS undergo bioaccumulation and cause deleterious effects such as oxidative stress, hepatoxicity, neurotoxicity, histopathological alterations, behavioral and growth abnormalities, reproductive toxicity and metabolism defects in freshwater and marine species. Regarding PFAS treatment methods, photodegradation, photocatalysis, and adsorption showed promising degradation approaches with efficiencies as high as 90%. Finally, research gaps and future perspectives for alternative PFAS toxicological implications and their removal were offered.